{"name":"IVI Madrid","slug":"ivi-madrid","ticker":"","exchange":"","domain":"","description":"IVI Madrid is a leading fertility clinic and research center dedicated to advancing reproductive medicine through innovative treatments and clinical trials. The company has a strong focus on developing new therapies for infertility, with several drugs in various stages of clinical development.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"oncology","drugs":[{"name":"Follitropin Delta, Recombinant","genericName":"Follitropin Delta, Recombinant","slug":"follitropin-delta-recombinant","indication":"Other","status":"phase_2"},{"name":"human menopausal gonadotropin","genericName":"human menopausal gonadotropin","slug":"human-menopausal-gonadotropin","indication":"Infertility in women undergoing assisted reproductive technology (ART) / in vitro fertilization (IVF)","status":"marketed"},{"name":"Biosimilar recombinant FSH","genericName":"Biosimilar recombinant FSH","slug":"biosimilar-recombinant-fsh","indication":"Infertility in women undergoing assisted reproductive technology (ART) / in vitro fertilization (IVF)","status":"marketed"},{"name":"Levonorgestrel and ethinylestradiol","genericName":"Levonorgestrel and ethinylestradiol","slug":"levonorgestrel-and-ethinylestradiol","indication":"Contraception / prevention of pregnancy","status":"marketed"},{"name":"Urinary FSH","genericName":"Urinary FSH","slug":"urinary-fsh","indication":"Ovarian stimulation in assisted reproductive technology (ART) cycles","status":"marketed"},{"name":"triptorelin, recombinant LH","genericName":"triptorelin, recombinant LH","slug":"triptorelin-recombinant-lh","indication":"Controlled ovarian stimulation in assisted reproductive technology (ART) / in vitro fertilization (IVF)","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Administration of letrozole","genericName":"Administration of letrozole","slug":"administration-of-letrozole","indication":"Hormone receptor-positive breast cancer in postmenopausal women (adjuvant and metastatic settings)","status":"phase_3"}]}],"pipeline":[{"name":"Follitropin Delta, Recombinant","genericName":"Follitropin Delta, Recombinant","slug":"follitropin-delta-recombinant","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"human menopausal gonadotropin","genericName":"human menopausal gonadotropin","slug":"human-menopausal-gonadotropin","phase":"marketed","mechanism":"Human menopausal gonadotropin (hMG) is a hormone preparation containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) that stimulates ovarian follicle development and maturation in women undergoing fertility treatment.","indications":["Infertility in women undergoing assisted reproductive technology (ART) / in vitro fertilization (IVF)","Anovulation and ovulatory disorders in women seeking pregnancy"],"catalyst":""},{"name":"Administration of letrozole","genericName":"Administration of letrozole","slug":"administration-of-letrozole","phase":"phase_3","mechanism":"Letrozole is an aromatase inhibitor that blocks the conversion of androgens to estrogen, reducing circulating estrogen levels in postmenopausal women.","indications":["Hormone receptor-positive breast cancer in postmenopausal women (adjuvant and metastatic settings)","Extended adjuvant therapy following tamoxifen in early-stage breast cancer","First-line treatment of advanced breast cancer"],"catalyst":""},{"name":"Biosimilar recombinant FSH","genericName":"Biosimilar recombinant FSH","slug":"biosimilar-recombinant-fsh","phase":"marketed","mechanism":"Biosimilar recombinant FSH stimulates the growth and maturation of ovarian follicles by binding to and activating follicle-stimulating hormone receptors on granulosa cells.","indications":["Infertility in women undergoing assisted reproductive technology (ART) / in vitro fertilization (IVF)","Anovulation and ovulatory disorders in women"],"catalyst":""},{"name":"Levonorgestrel and ethinylestradiol","genericName":"Levonorgestrel and ethinylestradiol","slug":"levonorgestrel-and-ethinylestradiol","phase":"marketed","mechanism":"Levonorgestrel and ethinylestradiol is a combined oral contraceptive that prevents ovulation by suppressing gonadotropin hormones and altering cervical mucus and endometrial conditions.","indications":["Contraception / prevention of pregnancy","Regulation of menstrual cycle"],"catalyst":""},{"name":"Urinary FSH","genericName":"Urinary FSH","slug":"urinary-fsh","phase":"marketed","mechanism":"Urinary FSH is a purified preparation of follicle-stimulating hormone extracted from human urine that stimulates follicle development and estrogen production in women undergoing fertility treatment.","indications":["Ovarian stimulation in assisted reproductive technology (ART) cycles","Anovulation and infertility in women"],"catalyst":""},{"name":"triptorelin, recombinant LH","genericName":"triptorelin, recombinant LH","slug":"triptorelin-recombinant-lh","phase":"marketed","mechanism":"Triptorelin is a GnRH agonist that stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to support reproductive function.","indications":["Controlled ovarian stimulation in assisted reproductive technology (ART) / in vitro fertilization (IVF)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":7,"phaseCounts":{"phase_2":1,"marketed":5,"phase_3":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}